BCL2 and lung cancer: The navitoclax is a potent small molecule inhibitor of Bcl-2 family and numerous of studies indicated that navitoclax exhibited therapeutic effect against multiple types of cancers, including lung cancer, acute lymphoblastic leukemia, and ovarian cancer etc. [34-36].